TREA

79300854 - GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE.

Follow

Information

  • Trademark
  • 79300854
  • Serial Number
    79300854
  • Registration Number
    6674439
  • Filing Date
    September 22, 2020
    4 years ago
  • Registration Date
    March 22, 2022
    2 years ago
  • Transaction Date
    September 11, 2022
    2 years ago
  • Status Date
    March 22, 2022
    2 years ago
  • Published for Opposition Date
    January 04, 2022
    3 years ago
  • Location Date
    March 22, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DYER, ERIN ZASKODA
  • Attorney Name
    Alexandra MacKay
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE.
Case File Statements
  • GS0411: Education services, namely, organizing and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals for the treatment of medical disorders and dissemination of materials in connection therewith; provision of training, namely, provision of training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals for the treatment of medical disorders and dissemination of materials in connection therewith
  • GS0441: Medical services; medical and pharmaceutical advisory and consultancy services; gene bank services
  • GS0421: Medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields; development of computer data banks containing information concerning gene expression and gene therapy; pharmaceutical drug development services
Case File Event Statements
  • 9/11/2022 - 2 years ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 8/12/2022 - 2 years ago
    32 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS
  • 8/12/2022 - 2 years ago
    31 - GENERIC MADRID TRANSACTION CREATED Type: XXCR
  • 6/22/2022 - 2 years ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 3/22/2022 - 2 years ago
    29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/4/2022 - 3 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/4/2022 - 3 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/1/2022 - 3 years ago
    26 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/15/2021 - 3 years ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/15/2021 - 3 years ago
    24 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/15/2021 - 3 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/1/2021 - 3 years ago
    22 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 11/30/2021 - 3 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/28/2021 - 3 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/28/2021 - 3 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/28/2021 - 3 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 10/23/2021 - 3 years ago
    17 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 10/1/2021 - 3 years ago
    16 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 10/1/2021 - 3 years ago
    15 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/1/2021 - 3 years ago
    14 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 8/31/2021 - 3 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/30/2021 - 3 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/30/2021 - 3 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/22/2021 - 3 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/2/2021 - 3 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/2/2021 - 3 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/23/2021 - 3 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/22/2021 - 3 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/9/2021 - 3 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/16/2021 - 3 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/12/2021 - 4 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/12/2021 - 4 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 12/24/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR